Calithera Biosciences, Inc. Gains 166.67%
Wed, Jul 26, 2023 at 07:30 PM
Calithera Biosciences, Inc. (CALA:NASDAQ) rocketted at $0.04, a gain of 166.7%. From Wed, Jul 12, 2023, the stock recorded 11.11% Up Days and 10.00% Green Days
About Calithera Biosciences, Inc. (CALA:NASDAQ)
Calithera Biosciences Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer.
Top 10 Gainers:
- Mallinckrodt plc (MNK:NYSEMKT), 186.36%
- Calithera Biosciences, Inc. (CALA:NASDAQ), 166.67%
- Vicor Corporation (VICR:NASDAQ), 57.72%
- Colombier Acquisition Corp. Class A (CLBR:NYSE), 54.51%
- AERWINS Technologies Inc Com (AWIN:NASDAQ), 44.93%
- Tupperware Brands Corporation (TUP:NYSE), 42.86%
- Aceragen Inc Com (ACGN:NASDAQ), 42.06%
- Armata Pharmaceuticals Inc. (ARMP:NYSEMKT), 39.09%
- NLS Pharmaceutics Ltd. (NLSP:NASDAQ), 38.41%
- SCWorx Corp. (WORX:NASDAQ), 33.44%